Phenyl methanesulfonamide derivatives useful as mgat-2 inhibitors

A compound of the formula below:

• wherein
• R1 is selected from:
• —CH3 and —CF3;
• R2 is selected from H, —C1-4alkyl, —C3-4cycloalkyl, —C1-2alkylcyclopropyl, —O—C1-2alkyl, phenyl, 2-benzothiazolyl, 2-pyridinyl, and 3-pyridinyl, wherein the phenyl is optionally substituted with 1 or 2 groups independently selected from:
• halogen, —C1-2alkyl, —CF3, —OC1-3alkyl, and —OC1-2haloalkyl, and the pyridinyl is optionally substituted with 1 or 2 groups independently selected from —CH3, halogen, —OCH2cyclopropyl, and —OC1-3alkyl;
• and
• R3 is selected from:
• H, —OC1-3alkyl, —OC1-2haloalkyl, phenyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, and 2-thiazolyl, wherein the phenyl is optionally substituted with a halogen;
• provided that if one of R2 and R3 is H then the other one of R2 and R3 is not H;
• or a pharmaceutically acceptable salt thereof.